More resources on HPV immunisation in New Zealand and overseas.
On this page:
- New Zealand sites
- International sites
- Downloadable resources
- Further reading
- Supporting statements
New Zealand sites
Medsafe is the medicines safety arm of the Ministry of Health and responsible for regulating medicines in New Zealand. On their website you can find their Consumer Information Sheet (PDF, 119 KB) and Datasheet (PDF, 768 KB) on the HPV vaccine, Gardasil®.
The New Zealand HPV Project aims to provide support and education for people with HPV.
The Immunisation Advisory Centre (part of the University of Auckland) provides a wealth of factual information about immunisation and vaccines for the public and health professionals.
The National Screening Unit runs and provides information about the National Cervical Screening Programme and smear tests.
The Centre for Adverse Reactions Monitoring monitors reactions to medicines such as vaccines.
The World Health Organization directs and coordinates health across the United Nations. It provides leadership on global health matters and evidence-based policy.
The Australian Department of Health and Aged Care provides information on the Australian HPV programme, including information on vaccine safety from the Australian Therapeutic Goods Administration.
The Food and Drug Administration is the regulatory authority for medicines in the USA.
The US Centers for Disease Control and Prevention is a world-leading authority on protecting populations from disease and disease control. Their website has comprehensive information about HPV and the HPV vaccine.
The European Medicines Agency is the regulatory authority for medicines in Europe.
The Society of Obstetricians and Gynaecologists of Canada has put together this website, which provides a wealth of information for teens, adults, parents, teachers and health professionals about HPV and the HPV vaccine.
Videos on HPV, cervical cancer, cervical screening and the HPV vaccine. Available to watch on YouTube.
How the HPV Vaccine Works
Explains how the immune system works and how vaccines teach your body to recognise germs such as HPV. Available to watch on YouTube.
- Ministry of Health, HPV Immunisation Programme National Implementation Strategic Overview (PDF, 610 KB), June 2008.
- Medsafe, Gardasil® Consumer Information Sheet (PDF, 119 KB).
- Medsafe, Gardasil® Datasheet (PDF, 768 KB).
- Immunisation Advisory Centre, University of Auckland, List of references used in the development of information about HPV immunisation (PDF, 78 KB), 2008.
- World Health Organization (WHO) – Summary Report Update on Human Papillomavirus and Related Cancers in New Zealand (PDF, 786 KB), 29 January 2010. A Summary Fact Sheet (PDF, 156 KB) is also available. WHO Position Paper on Human Papillomavirus Vaccines (PDF, 261 KB), 9 April 2009. Key references with PubMed extracts (where available) to the WHO HPV Position Paper (PDF, 156 KB), 9 April 2009.
- C K Fairley, J S Hocking, L C Gurrin et al. Rapid decline in presentations of genital warts one year after implementation of a quadrivalent human papillomavirus vaccination programme in young women (PDF, 126 KB), Sex Transm Infect 2009 85: 499-502.
- Information on the clinical trials – Quadrivalent Human Papillomavirus Vaccine – Recommendations of the (US) Advisory Committee on Immunization Practices (ACIP), 23 March 2007.
Ministry of Health
The Ministry of Health recommends a coordinated approach to the prevention of cervical cancer and other HPV-related diseases in New Zealand. This involves HPV immunisation, regular cervical screening, health education about behaviours that increase the risk of disease and the prompt diagnosis and treatment of precancerous lesions and cancer.
World Health Organization
The World Health Organization endorses HPV vaccination programmes as part of an integrated cervical cancer prevention strategy that includes cervical cancer screening and sexual health education. (WHO Position Paper on HPV Vaccination, Weekly Epidemiological Record, 9 April 2009.)
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) recommends the vaccination of females aged 9–26 years against HPV, with the initial vaccination target of females aged 11 or 12 years. Both Australia and New Zealand have initiated National HPV Vaccination Programmes, which are endorsed by the RANZCOG.
Family Planning endorses the HPV immunisation programme, supported by women having regular cervical smears, as the best protection for New Zealand women against cervical cancer. We encourage young women to join the immunisation programme which, alongside regular screening, gives them better protection than ever before against this disease which takes the lives of about 60 New Zealand women every year and which causes many more to have invasive treatment.
For further information, visit the Family Planning website.
NZ Gynaecological Cancer Foundation
The NZ Gynaecological Cancer Foundation (formerly the Silver Ribbon Foundation) fully supports initiatives to reduce the incidence of all forms of gynaecological cancers in New Zealand. The NZ Gynaecological Cancer Foundation welcomes and supports the HPV immunisation programme in New Zealand schools and recognises that HPV immunisation, along with regular cervical screening between the ages of 20 and 70, offers the most effective protection against cervical cancer.
For further information, visit the NZ Gynaecological Cancer Foundation website.